GX-I7
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for GX-I7, covering 2017-07-02 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy [Phase 2]